Enzyme Hydrophobic Sites and Allosteric Membrane Interactions Regulate Signaling and Mediators of Inflammation

Abstract

We will discuss how membranes interact allosterically with enzymes to regulate cell signaling and metabolic pathways leading to inflammation 1. We have recently used substrate lipidomics coupled with molecular dynamics to reveal enzyme specificity linked to hydrophobic binding sites for membrane phospholipid substrates 2. We discovered unexpected headgroup and acyl chain specificity for each of the major human phospholipase A2 (PLA2) enzymes that explains the observed specificity at a new structural level. We discovered that a unique hydrophobic binding site — and not each enzyme’s catalytic residues or polar headgroup binding site — dominates each enzyme’s specificity. Each PLA2 shows unique specificity for its required fatty acid ranging from pro‐inflammatory arachidonic acid to membrane remodeling linolenic acid, antibacterial saturated fatty acids, and oxidized fatty acids in low‐density lipoproteins. Each PLA2 releases a specific fatty acid after the enzyme associates allosterically with membranes and extracts a single phospholipid substrate into its catalytic site. Each enzyme can be blocked by stereospecific inhibitors 3 specific for that PLA2. After decades of research advancements, we can now correlate PLA2 specificity and inhibition potency with molecular structure and physiological function using a novel lipidomics platform.From the cell signaling and inflammation perspective, the omics revolution began with genomics, proteomics and metabolomics, but lipidomics now dominates as the largest number of cellular metabolites are lipids, many playing critical roles in cell signaling, and over 40,000 distinct molecular species have been identified by the LIPID MAPS Consortium (www.lipidmaps.org). We have also employed lipidomics analysis to characterize the in vivo role of specific PLA2 enzymes in initiating the inflammatory response and cellular lipid signaling of Toll‐like (TLR4) and purinergic (P2X7) receptors in stimulated macrophages as models of bacterial infection and inflammation 4. We can now explain in vitro enzyme specificity with in vivo specificity, inhibition and pro‐inflammatory and pro‐resolution lipid mediator formation pathways and inhibition 5.Support or Funding InformationNIHGM20501‐45